News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Becton, Dickinson and Company (BDX) Announces Award to National Health Service Supply Chain Framework Agreement


12/10/2012 12:50:38 PM

Oxford, UK (December 2012) - BD (Becton, Dickinson and Company), a leading global medical technology company, is proud to accept its successful award to NHS Supply Chain’s National Microbiology Framework Agreement. NHS Supply Chain provides patient-focused healthcare products and supply chain services to the UK’s National Health Service (NHS). The agreement covers a comprehensive product range that sit within the Microbiology department.

Providing customer focussed supply chain services, giving customers a single point of access to thousands of products nationally, BD’s acknowledged award is a step forward in the changing landscape.

The following product areas will be covered via NHS Supply Chain’s Framework Agreement:

• Microbiological Identification Kits: Biochemical, Agglutination Tests

• Manual Antimicrobial Susceptibility Testing

• Pre-Poured Culture Media and Broth

• Automated Blood Culture

• Automated Identification and Susceptibility Analysers

• Automated Identification of Tuberculosis System

• Plate Streakers

• Automated Identification – Maldi TOF (In partnership with Bruker Daltonics)

For further information about BD’s award to NHS Supply Chain’s National Microbiology Framework Agreement, including when products will be available to purchase and how NHS Supply Chain can support your trust set-up specific products for ordering, please visit: www.supplychain.nhs.uk

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES